Evidence map›Paper›PMID 29632547›Full record

ReviewAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2018

Critical view of anaphylaxis epidemiology: open questions and new perspectives.

Luciana Kase Tanno, Ana Luiza Bierrenbach, F Estelle R Simons, Victoria Cardona, Bernard Yu-Hor Thong, Nicolas Molinari, Moises A Calderon, Margitta Worm, Yoon-Seok Chang, Nikolaos G Papadopoulos and 3 more

Abstract readReview
In one paragraph

Review in Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Who is at-risk for severe anaphylaxis in France?The World Allergy Organization journal · 2024
    Article
  8. Anaphylaxis in a Swiss university emergency department: clinical characteristics and supposed triggers.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024
    Article
  9. Article
  10. Article
  11. Global disparities in availability of epinephrine auto-injectors.The World Allergy Organization journal · 2023
    Article
  12. Mast Cells and Basophils in IgE-Independent Anaphylaxis.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Idiopathic Anaphylaxis? Analysis of Data from the Anaphylaxis Registry for West Pomerania Province, Poland.International journal of environmental research and public health · 2022
    Article
  17. Food allergy in the World Health Organization's International Classification of Diseases (ICD)-11.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Review
  18. Article
  19. Anaphylaxis in Brazil between 2011 and 2019.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Luciana Kase Tanno1Hospital Sírio Libanês, São Paulo, Brazil.
Ana Luiza BierrenbachSanas Epidemiology and Research, São Paulo, Brazil.
F Estelle R Simons6Section of Allergy & Clinical Immunology, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Canada.
Victoria Cardona7Allergy Section, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Bernard Yu-Hor Thong8Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore.
Nicolas Molinari9IMAG, UMR 5149, DIM CHRU de Montpellier, Montpellier, France.
Moises A Calderon10Section of Allergy and Clinical Immunology, Imperial College London, National Heart and Lung Institute, Royal Brompton Hospital, London, UK.
Margitta Worm11Allergie-Centrum-Charité, Klinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.
Yoon-Seok Chang12Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Gyeonggi-do South Korea.
Nikolaos G Papadopoulos13Centre for Paediatrics and Child Health Institute of Human Development, University of Manchester, Manchester, UK.
Thomas Casale15American Academy of Allergy Asthma and Immunology, and Morsani College of Medicine, University of South Florida, Tampa, FL USA.
Pascal Demoly2University Hospital of Montpellier, Montpellier, France.
on behalf the Joint Allergy Academies

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In contrast to the majority of allergic or hypersensitivity conditions, worldwide anaphylaxis epidemiological data remain sparse with low accuracy, which hampers comparable morbidity statistics. Data can differ widely depending on a number of variables. In the current document we reviewed the forms on which anaphylaxis has been defined and classified; and how it can affect epidemiological data. With regards to the methods used to capture morbidity statistics, we observed the impact of the anaphylaxis coding utilizing the World Health Organization's International Classification of Diseases. As an outcome and depending on the anaphylaxis definition, we extracted the cumulative incidence, which may not reflect the real number of new cases. The new ICD-11 anaphylaxis subsection developments and critical view of morbidity statistics data are discussed in order to reach new perspectives on anaphylaxis epidemiology.

Indexed as

AnaphylaxisClassificationEpidemiologyInternational Classification of DiseasesRare diseasesWorld Health Organization

Identifiers

PMID29632547
PMCPMC5883526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.